CXA Group Revenue and Competitors

CXA Group is Asia's one-stop, predictive and data intelligence platform for better health, wealth and wellness choices. Through the CXA platform, employers can empower employees with access to personalised health and lifestyle offerings, with clear and quantifiable ROI for the business. We enable employers to leverage their existing healthcare and insurance spend to pay for flexible benefits, corporate wellness and disease management initiatives in order to improve health, combat chronic disease and reduce costs while allowing for employee personalization via an e-wallet and AI. Headquartered in Singapore, CXA achieved revenue growth of 65 percent in 2018 and is expected to double that in 2019. It announced a funding round in March 2019 of USD 25 million. This follows US$33 million in total funding from Series A and B in 2015 and 2017 respectively. CXA's investors include HSBC, Singtel Innov8, Telkom Indonesia MDI Ventures, Sumitomo Corporation Equity Asia, Muang Thai Fuchsia Ventures, Humanica and Heritas Venture Fund B Capital Group, Openspace Ventures, Government-linked strategic investor EDBI, BioVeda Capital, FengHe Asia, Philips and RGAx. Driven by a team of industry veterans with extensive leadership experience across Asia's human resource, insurance, finance, healthcare and technology industries, CXA serves more than 600 enterprises, including Fortune 500 companies, and more than 400,000 employees in 20 countries. CXA has received recognition as InsurTech of the Year from the Asia Insurance Industry Awards and was among the top three most impactful innovations at the Singapore Digital Techblazer Awards. We were also voted Best Corporate Wellness Consultant and Best Compensation & Benefits Consultant, Best Corporate Employee Rewards and won the Asian Insurance Innovation Award. CXA was one of only 7 global health tech startups to be selected to join the Innovations in Healthcare network founded by Duke Health, McKinsey & Co., and the World Economic Forum